Pfizer is listed on the US stock exchange Na Nasdaq. You can follow the stock’s development below.
Pfizer is one of the world’s largest pharmaceutical companies with annual sales close to $ 50 billion. Pfizer also spends a significant amount on research and development, close to $ 8 billion annually.
While Pfizer has historically sold many types of health products and medicines, prescription medicines and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular therapy Eliquis and immunology drug Xeljanz.
Pfizer and BioNTech have jointly developed the long-awaited corona vaccine, which at the time of writing is the best vaccine.
Pfizer sells these products globally, with international sales representing nearly 50% total sales. In international sales, new markets are an important contributor.